Expertise in
14
conditions

Fengkui K. Zhang

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Tianjin, CN 
Expertise in
14
conditions
State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, 
Tianjin, CN 

Overview

Fengkui Zhang practices practicing medicine in Tianjin, China.

Zhang is highly rated in 14 conditions, according to our data. Their clinical expertise encompasses Aplastic Anemia, Anemia, Hereditary Spherocytosis, Hemolysis, and Bone Marrow Transplant.

They are actively involved in clinical research, co-authoring 145 peer reviewed articles and participating in 1 clinical trial.

Locations

State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, Tianjin, China
Other Locations
Chinese Academy Of Medical Science And Peking Union Medical College, Beijing, China
State Key Laboratory Of Experimental Hematology, Chinese Academy Of Medical Sciences & Peking Union Medical College, No. 288 Nanjing Rd. Heping District, Xiaobailou, 300020, China
300020, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Extension Study of Hetrombopag Olamine in Patients With Treatment-naive Severe Aplastic Anemia
Extension Study of Hetrombopag Olamine in Patients With Treatment-naive Severe Aplastic Anemia
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Hetrombopag Olamine
Study Phase: Phase 3

145 Total Publications

A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics.
A 53-week, open-label phase IIIb study of velaglucerase alfa in Chinese patients with type 1 Gaucher disease: Safety, efficacy, and pharmacokinetics.
Journal: Molecular genetics and metabolism reports
Published: March 02, 2026

Frequently Asked Questions about Fengkui K. Zhang

Is Fengkui K. Zhang a top-rated expert for Aplastic Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Fengkui K. Zhang is classified as an Elite expert for Aplastic Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Fengkui K. Zhang participate in research or clinical trials?

Yes. Fengkui K. Zhang has published 145 articles and abstracts on conditions like Aplastic Anemia. You can view a list of Fengkui K. Zhang's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Zhang's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 25 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile